MOTS-C × hightidecompounds peptides — lab test, lot MS10-005, August 2026
COA KVR-2026-A42783 matches Kovera Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
CH56N96Test results
About this test
Label 10 mg · Lab measured 9.19 mg
92% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 2.3 mg using the measured mass, against 2.5 mg on the label — 8% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | KVR-2026-A42783 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 25 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Kovera Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of MOTS-C from hightidecompounds peptides, performed by Kovera Labs on August 19, 2026. Reported purity: 99.855%. Net content: 9.19 mg against 10 mg labeled (92% of label). Endotoxins: <0.5 EU/mL PASS. Heavy metals: As, Cd, Pb, Hg — all Negative. Batch MS10-005. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of MOTS-C from hightidecompounds peptides
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| MS10-004 | 19 Aug 2026 | Kovera Labs | 99.704% | 99% | ✓ Lab-verified |
| MS40-001 | 6 Aug 2026 | Kovera Labs | 99.555% | 107% | ✓ Lab-verified |
| MS10-003 | 15 Jul 2026 | Kovera Labs | 99.558% | 102% | ✓ Lab-verified |
| MS10-002 | 20 Jun 2026 | Kovera Labs | 99.391% | 106% | ✓ Lab-verified |
| MOT10-001 | 26 May 2026 | Kovera Labs | 98.833% | 96% | ✓ Lab-verified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion